Myc In Various Cancers - Genetic Mutations

Relevant Publications

Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma.

Issue Release: 2024

Target deubiquitinase OTUB1 as a therapeatic strategy for BLCA via β-catenin/necroptosis signal pathway.

Issue Release: 2024

PDE4B promotes the progression of gastric cancer via the PI3K/AKT/MYC pathway and immune infiltration.

Issue Release: 2024

Biological and prognostic significance of NDRG2 downregulation in oral squamous cell carcinoma.

Issue Release: 2024

Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes.

Issue Release: 2024

Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers.

Issue Release: 2024

Targeted variant prevalence of FBXW7 gene mutation in colorectal carcinoma propagation. The first systematic review and meta-analysis.

Issue Release: 2024

NF-κB-activated oncogene inhibition strategy for cancer gene therapy.

Issue Release: 2024

TNFSF12 is associated with breast cancer prognosis and immune cell infiltration.

Issue Release: 2024

Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS-mutant Cancers.

Issue Release: 2024

The small nucleolar RNA SNORA51 enhances breast cancer stem cell-like properties via the RPL3/NPM1/c-MYC pathway.

Issue Release: 2024

Stomatin-like protein 2 promotes cell proliferation and survival under 5-Fluorouracil stress in hepatocellular carcinoma.

Issue Release: 2024

Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry.

Issue Release: 2024

Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute Leukemia.

Issue Release: 2024

E2F transcription factor-1 modulates expression of glutamine metabolic genes in mouse embryonic fibroblasts and uterine sarcoma cells.

Issue Release: 2024

FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.

Issue Release: 2024

Recurrent mutations in tumor suppressor bypass Wnt/β-catenin addiction in cancer.

Issue Release: 2024

PICH deficiency limits the progression of MYC-induced B-cell lymphoma.

Issue Release: 2024

Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma.

Issue Release: 2024

GNA13 suppresses proliferation of ER+ breast cancer cells via ERα dependent upregulation of the MYC oncogene.

Issue Release: 2024

How Does Genetics Influence Occupational Therapy?

What Are Some Key Considerations for Successful Sanger Sequencing?

How do Acridine Dyes Cause Mutations?

How Do These Mutagens Affect DNA?

What Is the Role of Mutations in Evolution?

How are Genetic Mutations Identified?

Can Insertion Mutations Lead to Diseases?

What are the Future Directions?

Should Genetic Mutations Be Patented?

What Are the Consequences of Transversions?

Partnered Content Networks

Relevant Topics